BiondVax Pharmaceuticals Ltd. | CIK:0001611747 | 3

  • Filed: 4/30/2018
  • Entity registrant name: BiondVax Pharmaceuticals Ltd. (CIK: 0001611747)
  • Generator: Ez-XBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1611747/000121390018005179/0001213900-18-005179-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1611747/000121390018005179/bvxv-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001611747
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory

                           

    Convenience translation

    (Note 2c)

     
         

    Year ended December 31,

       

    Year ended

    December 31,

     
          2015     2016     2017     2017  
          N I S     U.S. dollars  
                                       
      Salaries and related expenses     3,796       3,808       3,695     $ 1,066  
      Share-based payment     588       903       388       112  
      Patent registration fees     617       358       322       92  
      Rentals and maintenance of laboratory     607       610       610       153  
      Materials and subcontractors     4,633       3,145       3,797       1,118  
      Revaluation of the liability with respect to the IIA grants     -       -       10,300       2,971  
      Depreciation     495       573       311       90  
                                       
            10,736       9,397       19,423       5,602  
                                       
      Participation by IIA and UNISEC     (2,830 )     (1,603 )     (646 )     (186 )
                                       
            7,906       7,794       18,777     $ 5,416